Awareness of Smoking As a Risk Factor For Bladder Cancer: A Cross-Sectional Study in Jordan

Authors

  • Nour Alhouda Alsyouri School of Medicine, University of Jordan, Amman, Jordan
  • Waed Al Shdifat School of Medicine, University of Jordan, Amman, Jordan
  • Ahmad Toubasi School of Medicine, University of Jordan, Amman, Jordan
  • Sereen Halayqeh School of Medicine, University of Jordan, Amman, Jordan
  • Ahmed F. Al-hammouri School of Medicine, University of Jordan, Amman, Jordan
  • Abdelmuez Siyam School of Medicine, University of Jordan, Amman, Jordan
  • Mohammad Abufaraj School of Medicine, University of Jordan, Amman, Jordan

DOI:

https://doi.org/10.35516/jmj.v59i2.2002

Keywords:

Awareness, bladder cancer, Jordan, risk factor, smoking.

Abstract

Background and Aims: Bladder cancer (BCa) is a relatively common cancer, ranking 10th worldwide and the 6th most common tumor in Jordan. Smoking is considered the most important risk factor for bladder cancer, and in Jordan, there is a high documented smoking rate (65% in males and 42% in both sexes).

Our aim is to evaluate the awareness of smoking as a risk factor for BCa among a sample of the Jordanian population.

Materials and Methods: This quantitative population-based cross-sectional study used an online structured self-administered questionnaire to collect data from a sample of 726 participants who were selected from the most populated governorates of Jordan. They were queried about their demographics, smoking status, and knowledge regarding smoking as a risk factor for BCa among other multiple medical conditions.

Results: Overall, 400 (55.1%) of the participants were females and 203 (28%) were active smokers. Although 50.6% of the participants knew that smoking is a risk factor for BCa only 25% indicated that it is the most important risk factor. In addition, awareness of smoking as a risk factor for other medical conditions such as lung cancer, heart diseases and oral cancer was significantly higher than that of BCa.

Conclusion: The overall knowledge among our sample regarding the relationship between BCa and smoking is not satisfactory highlighting the need to raise the awareness of smoking effect on BCa.

References

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. (2021); 71(3), 209–249.

Omar Nimri, Ghazi Sharkas, Nashat Tan'ni . Cancer Incidence in Jordan - 2017 [Statistical digest]. Jordan Cancer Registry. (2017).

Saginala, K., Barsouk, A., Aluru, J. S., Rawla, P., Padala, S. A., & Barsouk, A. Epidemiology of Bladder Cancer. Medical sciences (Basel, Switzerland). (2020); 8(1), 15.

Jordan Ministry of Health. Jordan National Stepwise Survey (STEPs) for Noncommunicable Diseases Risk Factors 2019 [Fact sheet]. (2020).

Bassett, J. C., Gore, J. L., Kwan, L., Ritch, C. R., Barocas, D. A., Penson, D. F., McCarthy, W. J., & Saigal, C. S. Knowledge of the harms of tobacco use among patients with bladder cancer. Cancer. (2014); 120(24), 3914–3922.

Nieder, A. M., John, S., Messina, C. R., Granek, I. A., & Adler, H. L. Are patients aware of the association between smoking and bladder cancer?. The Journal of urology. (2006); 176(6 Pt 1), 2405–2408.

Mota, P., Sousa, P. M., Botelho, F., Carvalho-Dias, E., Cordeiro, A., Torres, J. P., Morais, N., Anacleto, S., & Lima, E. Cessação Tabágica após o Diagnóstico de Cancro da Bexiga [Smoking Cessation after Bladder Cancer Diagnosis]. Acta medica portuguesa. (2018); 31(2), 101–108.

Mithani, M. H., Khan, S. A., Khalid, S. E., Siddique, R., Humayun, H., & Awan, A. S. Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: A prospective survey. JPMA. The Journal of the Pakistan Medical Association. (2018); 68(1), 55–58.

Sell, V., Ettala, O., Perez, I. M., Järvinen, R., Pekkarinen, T., Vaarala, M., Seppänen, M., Liukkonen, T., Marttila, T., Aaltomaa, S., & Boström, P. J. Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial. European urology focus. (2022); 8(5), 1246–1252.

Yuruk, E., Tuken, M., Colakerol, A., & Serefoglu, E. C. The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs. International braz j urol : official journal of the Brazilian Society of Urology. (2017). 43(4), 607–614.

Souaid, T., Hindy, J. R., Eid, R., Kourie, H. R., & Kattan, J. Bladder cancer knowledge in the Lebanese population: When ignorance could be harmful. Bulletin du cancer. (2018); 105(10), 857–861.

Karam AM, Alshrouf MA, Albandi AM, et al. Awareness of Bladder Cancer Symptoms and Risk Factors in Jordan: A Nationwide Study. Asia Pacific Journal of Public Health. 2023;35(1):69-72.

Mossanen, M., & Gore, J. L. The burden of bladder cancer care: direct and indirect costs. Current opinion in urology. (2014); 24(5), 487–491

Sievert, K. D., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., Hennenlotter, J., Kruck, S., & Stenzl, A. Economic aspects of bladder cancer: what are the benefits and costs?. World journal of urology. (2009); 27(3), 295–300.

Fleshner N, Garland J, Moadel A et al .Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. (1999); 86:2337–2345

Anastasiou, I., Mygdalis, V., Mihalakis, A., Adamakis, I., Constantinides, C., & Mitropoulos, D. Patient awareness of smoking as a risk factor for bladder cancer. International urology and nephrology. (2010); 42(2), 309–314.

Khan, M., Papa, N., Manning, T., Nzenza, T., Simionato, L., & Lawrentschuk, N. Knowledge of smoking as a risk factor for disease among urology clinic patients in Australia. World journal of urology. (2018); 36(8), 1219–1224.

Almannie, R. M., Abunayan, M. S., Alkhayal, A. M., Alzahrani, A. Y., Alzahrani, T. M., Binsaleh, S. A., & Alyami, F. A. Saudi patient knowledge and awareness regarding smoking as a risk factor for urological diseases. Urology annals. (2022); 14(1), 67–72.

Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. Tobacco smoking and cancer: a meta-analysis. International journal of cancer. (2008); 122(1), 155–164.

Johnson, B., Abouassaly, R., Ghiculete, D., & Stewart, R. J. Evaluating the effectiveness of a smoking warning label on raising patient awareness of smoking and bladder cancer. The Journal of urology. (2013); 190(2), 475–479

(21) Bjurlin, M. A., Cohn, M. R., Freeman, V. L., Lombardo, L. M., Hurley, S. D., & Hollowell, C. M. (2012). Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases. The Journal of urology, 188(3), 724–728.

Downloads

Published

2025-04-27

How to Cite

Alsyouri, N. A., Shdifat, W. A. ., Toubasi, A. ., Halayqeh, S. ., Al-hammouri, A. F. ., Siyam, A. ., & Abufaraj, M. . (2025). Awareness of Smoking As a Risk Factor For Bladder Cancer: A Cross-Sectional Study in Jordan . Jordan Medical Journal, 59(2). https://doi.org/10.35516/jmj.v59i2.2002

Issue

Section

Articles